These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6511252)

  • 21. Anticoagulant effects of protamine sulfate in a canine model.
    Kresowik TF; Wakefield TW; Fessler RD; Stanley JC
    J Surg Res; 1988 Jul; 45(1):8-14. PubMed ID: 3392995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental studies of heparin-protamine activity with special reference to protamine inhibition of clotting.
    ANDERSEN MN; MENDELOW M; ALFANO GA
    Surgery; 1959 Dec; 46():1060-8. PubMed ID: 13793331
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of unfractionated heparin, low-molecular-weight heparin, and heparinoid on thromboelastographic assay of blood coagulation.
    Zmuda K; Neofotistos D; Ts'ao CH
    Am J Clin Pathol; 2000 May; 113(5):725-31. PubMed ID: 10800406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Polylysine on Blood Clotting, and Red Blood Cell Morphology, Aggregation and Hemolysis.
    Zhang W; Liu F
    J Nanosci Nanotechnol; 2017 Jan; 17(1):251-55. PubMed ID: 29620337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolonged Activated Clotting Time after Protamine Administration Does Not Indicate Residual Heparinization after Cardiopulmonary Bypass in Pediatric Open Heart Surgery.
    Yamamoto T; Wolf HG; Sinzobahamvya N; Asfour B; Hraska V; Schindler E
    Thorac Cardiovasc Surg; 2015 Aug; 63(5):397-403. PubMed ID: 26121380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of temperature on blood flow ultrasonic echogenicity in vitro.
    Beitler JC; Sigel B; Machi J; Justin JR
    J Ultrasound Med; 1983 Dec; 2(12):529-33. PubMed ID: 6655782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of protamine sulfate with thrombin.
    Cobel-Geard RJ; Hassouna HI
    Am J Hematol; 1983 May; 14(3):227-33. PubMed ID: 6846326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hematologic changes occurring with cardiac catheterization.
    Friedman HS; Trivelli LA; Nguyen T; Benamor R; Dorsa M
    Cathet Cardiovasc Diagn; 1988; 15(2):89-91. PubMed ID: 3180213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective heparinization of the extracorporeal membrane oxygenation circuit using continuous infusions of protamine and heparin in a short-term pig model.
    Dickey LA; Butler TJ; Bergmann TM; Bates ME; Null DM
    Perfusion; 1994; 9(5):327-33. PubMed ID: 7833540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of blood flow and the effect of protamine on the thromboresistant properties of a covalently bonded heparin surface.
    Arnander C; Olsson P; Larm O
    J Biomed Mater Res; 1988 Oct; 22(10):859-68. PubMed ID: 3220839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (Fragmin) at the site of activation of the coagulation system in man.
    Wolzt M; Weltermann A; Nieszpaur-Los M; Schneider B; Fassolt A; Lechner K; Eichler HG; Kyrle PA
    Thromb Haemost; 1995 Mar; 73(3):439-43. PubMed ID: 7667826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heparinase I (neutralase) reversal of systemic anticoagulation.
    Michelsen LG; Kikura M; Levy JH; Lee MK; Lee KC; Zimmermann JJ; Szlam F
    Anesthesiology; 1996 Aug; 85(2):339-46. PubMed ID: 8712450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neutralization of low molecular weight heparin Kabi 2165 by protamine chloride].
    Harenberg J; Giese C; Knödler A; Zimmermann R; Schettler G
    Klin Wochenschr; 1986 Nov; 64(22):1171-5. PubMed ID: 3807263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of protamine and heparin can be detected and easily differentiated by modified thrombelastography (Rotem): an in vitro study.
    Mittermayr M; Margreiter J; Velik-Salchner C; Klingler A; Streif W; Fries D; Innerhofer P
    Br J Anaesth; 2005 Sep; 95(3):310-6. PubMed ID: 16024582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cationic derivative of dextran reverses anticoagulant activity of unfractionated heparin in animal models of arterial and venous thrombosis.
    Kalaska B; Sokolowska E; Kaminski K; Szczubialka K; Kramkowski K; Mogielnicki A; Nowakowska M; Buczko W
    Eur J Pharmacol; 2012 Jul; 686(1-3):81-9. PubMed ID: 22579410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of the quantitative action of protamine and heparin on blood coagulation. Significance in clinical and laboratory usage.
    Perkash A
    Am J Clin Pathol; 1980 May; 73(5):676-81. PubMed ID: 7377134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention and dispersion of contrast media induced red cell aggregates. An in vitro study.
    Raininko R; Ylinen SL
    Acta Radiol; 1990 May; 31(3):309-14. PubMed ID: 2386644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relative neutralization of the biological actions of sulfaminoheparosans (K5 derivatives) and heparins by protamine sulfate.
    Maddineni J; Hoppensteadt DA; Cornelli U; Manoni M; Fareed J
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):52-64. PubMed ID: 17164496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neutralase reverses the anti-coagulant but not the anti-thrombotic activity of heparin in a rabbit model of venous thrombosis.
    Silver PJ; Broughton R; Bouthillier J; Quinn TA; Wallace AM; Weishaar RE
    Thromb Res; 1998 Aug; 91(3):143-50. PubMed ID: 9733158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optical aggregometry of red blood cells associated with the blood-clotting reaction in extracorporeal circulation support.
    Sakota D; Kosaka R; Nishida M; Maruyama O
    J Artif Organs; 2016 Sep; 19(3):241-8. PubMed ID: 27010641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.